Company profile for Meitheal Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Meitheal Pharmaceuticals is a fully integrated R&D, manufacturing and commercial company. Dedicated to supplying high quality, affordable generic injectables to the U.S. healthcare market. Easy to do business with. In 2017, we set out to bridge important gaps in the market. Namely, the need for: Generic injectables. We made significant investments in generics, and continue to do so, when other producers are scaling back. Beca...
Meitheal Pharmaceuticals is a fully integrated R&D, manufacturing and commercial company. Dedicated to supplying high quality, affordable generic injectables to the U.S. healthcare market. Easy to do business with. In 2017, we set out to bridge important gaps in the market. Namely, the need for: Generic injectables. We made significant investments in generics, and continue to do so, when other producers are scaling back. Because where they have growing priorities elsewhere, we see an even bigger need for a reliable supply of these life sustaining drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
8700 W. Bryn Mawr, Suite 600S Chicago, IL 60631
Telephone
Telephone
(224) 443 4617
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251104528525/en/Meitheal-Pharmaceuticals-Receives-Approval-from-the-US-Food-and-Drug-Administration-for-CONTEPO-fosfomycin-for-injection-in-Patients-18-Years-Having-Complicated-Urinary-Tract-Infections-cUTI-Including-Acute-Pyelonephritis-AP

BUSINESSWIRE
04 Nov 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212271

FDA
22 Oct 2025

https://www.businesswire.com/news/home/20251020126688/en/Meitheal-Pharmaceuticals-to-Present-New-Data-in-Infectious-Disease-Portfolio-at-IDWeek-2025

BUSINESSWIRE
20 Oct 2025

https://www.contractpharma.com/breaking-news/meitheal-pharmaceuticals-expands-medical-affairs-operations-with-two-appointments/

CONTRACTPHARMA
31 Jul 2025

https://www.businesswire.com/news/home/20250731498961/en/Meitheal-Pharmaceuticals-Announces-Appointment-of-Dr.-Keith-Robinson-as-Chief-Medical-Officer-and-Expansion-of-Medical-Affairs-Operation

BUSINESSWIRE
31 Jul 2025

https://www.businesswire.com/news/home/20250529061176/en/Meitheal-Pharmaceuticals-Announces-Launch-of-Generic-Paclitaxel-Formulation-in-the-United-States-Through-Exclusive-Commercial-Licensing-Agreement

BUSINESSWIRE
29 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty